Dr Sulaiman Al Habib Medical Services (4013) Q2 2025 earnings summary

Executive summary

• Achieved strong revenue and profit growth in Q2 and H1 2025, driven by expansion and operational excellence.

• Revenue for the six months ended 30 June 2025 reached SAR 6.54 billion, up from SAR 5.10 billion year-over-year.

• Net profit for the six-month period was SAR 1.18 billion, compared to SAR 1.13 billion in the prior year.

• Opened multiple new hospitals, enhancing market leadership and geographic footprint.

• Total assets increased to SAR 22.48 billion as of 30 June 2025, up from SAR 20.56 billion at year-end 2024.

Financial highlights

• Q2 2025 revenue rose 31.5% year-over-year to SAR 3,384 million; gross profit up 21.4%.

• Q2 2025 EBITDA increased 35.5% to SAR 878 million; net income up 25.6% to SAR 695 million.

• H1 2025 revenue grew 28.4% to SAR 6,542 million; net income up 3.8% to SAR 1,148 million.

• Gross profit for the six months was SAR 2.09 billion, up from SAR 1.76 billion year-over-year.

• Basic and diluted EPS for the six months was SAR 3.28, up from SAR 3.16 year-over-year.

Outlook and guidance

• Robust expansion plans with new hospitals under construction and future projects in Tabuk and Jubail.

• Focus on technology, operational efficiency, and sustainability to drive long-term growth.

• The interim financial statements are prepared as part of the fiscal year and may not indicate full-year results.